Prevalence and mortality in β-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience.
作者信息
Karimi Mehran, Haghpanah Sezaneh, Azarkeivan Azita, Zahedi Zohreh, Zarei Tahereh, Akhavan Tavakoli Maryam, Bazrafshan Asghar, Shirkavand Afshan, De Sanctis Vincezo
机构信息
Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Zafar Adult Thalassemia Clinic, Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
出版信息
Br J Haematol. 2020 Aug;190(3):e137-e140. doi: 10.1111/bjh.16911. Epub 2020 Jun 30.
Abstract
摘要
相似文献
1
Prevalence and mortality in β-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience.新型冠状病毒病（COVID-19）爆发导致的β地中海贫血的患病率和死亡率：伊朗全国的经验。
Br J Haematol. 2020 Aug;190(3):e137-e140. doi: 10.1111/bjh.16911. Epub 2020 Jun 30.
2
Prevalence and severity of Coronavirus disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β-thalassemia patients and effects of associated comorbidities: an Iranian nationwide study.输血依赖型和非输血依赖型β地中海贫血患者中2019冠状病毒病（COVID-19）的患病率、严重程度及相关合并症的影响：一项伊朗全国性研究
Acta Biomed. 2020 Sep 7;91(3):e2020007. doi: 10.23750/abm.v91i3.10155.
3
SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience.β地中海贫血患者的新型冠状病毒2型感染：来自意大利经验的初步数据。
Am J Hematol. 2020 Aug;95(8):E198-E199. doi: 10.1002/ajh.25840. Epub 2020 May 6.
4
Beta-thalassemia may protect against COVID 19.β地中海贫血可能对新型冠状病毒肺炎有防护作用。
Med Hypotheses. 2020 Oct;143:110014. doi: 10.1016/j.mehy.2020.110014. Epub 2020 Jun 28.
5
The Coronavirus Disease 2019 (COVID-19) and Alcohol Use Disorders in Iran.伊朗的2019冠状病毒病（COVID-19）与酒精使用障碍
Am J Mens Health. 2020 Jul-Aug;14(4):1557988320938610. doi: 10.1177/1557988320938610.
6
The COVID-19 Outbreak: An Experience for Iranian Health Systems and Orthopedics Association.新冠疫情：伊朗卫生系统与骨科学会的一次经历
Arch Iran Med. 2020 Aug 1;23(8):570-571. doi: 10.34172/aim.2020.63.
7
Challenging Times for Children With Transfusion-dependent Thalassemia Amid the COVID-19 Pandemic.新冠疫情期间，依赖输血的地中海贫血患儿面临严峻挑战。
Indian Pediatr. 2020 May 15;57(5):478. doi: 10.1007/s13312-020-1831-9. Epub 2020 Apr 11.
8
Letter to the Editor "Effects of Coronavirus Disease 2019 (COVID-19) Pandemic on Neurological Surgery Care and Education; Our Experience from Iran".致编辑的信《2019年冠状病毒病（COVID-19）大流行对神经外科护理与教育的影响；我们在伊朗的经验》
World Neurosurg. 2020 Jul;139:376. doi: 10.1016/j.wneu.2020.05.058. Epub 2020 May 13.
9
Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems.伊朗2019冠状病毒病（COVID-19）疫情：行动与问题
Infect Control Hosp Epidemiol. 2020 Jun;41(6):754-755. doi: 10.1017/ice.2020.86.
10
One Aspect of Coronavirus disease (COVID-19) Outbreak in Iran: High Anxiety among MS Patients.冠状病毒病（COVID-19）在伊朗爆发的一个方面：多发性硬化症患者高度焦虑。
Mult Scler Relat Disord. 2020 Jun;41:102138. doi: 10.1016/j.msard.2020.102138. Epub 2020 Apr 20.
引用本文的文献
1
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience.血红蛋白病患者接种新型冠状病毒疫苗后的免疫反应及突破性感染风险：单中心经验
Vaccines (Basel). 2025 Jan 23;13(2):111. doi: 10.3390/vaccines13020111.
2
Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience.COVID-19 大流行对血红蛋白病患者 MRI 铁过载评估的影响：E-MIOT 网络的经验。
Tomography. 2023 Sep 11;9(5):1711-1722. doi: 10.3390/tomography9050136.
3
Prevention and treatment of COVID-19 in patients with benign and malignant blood disorders.防治血液良恶性疾病患者的 COVID-19。
Best Pract Res Clin Haematol. 2022 Sep;35(3):101375. doi: 10.1016/j.beha.2022.101375. Epub 2022 Aug 24.
4
Reply - Letter to the editor: "Micronutrient supplementation, COVID-19 vaccination and adverse effect".致编辑的回信：“微量营养素补充、新冠疫苗接种与不良反应”
Clin Nutr ESPEN. 2022 Jun;49:678. doi: 10.1016/j.clnesp.2022.02.117. Epub 2022 Mar 4.
5
Efficacy and Safety of Sinopharm Vaccine for SARS-CoV-2 and breakthrough infections in Iranian Patients with Hemoglobinopathies: A Preliminary Report.国药集团新冠疫苗对伊朗血红蛋白病患者的疗效、安全性及突破性感染情况：初步报告
Mediterr J Hematol Infect Dis. 2022 Mar 1;14(1):e2022026. doi: 10.4084/MJHID.2022.026. eCollection 2022.
6
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry.地中海贫血症与 COVID-19 住院并发症和死亡率降低呈矛盾相关：来自国际登记处的数据。
J Cell Mol Med. 2022 May;26(9):2520-2528. doi: 10.1111/jcmm.17026. Epub 2022 Mar 30.
7
Vulnerability of β-Thalassemia Heterozygotes to COVID-19: Results from a Cohort Study.β地中海贫血杂合子对新冠病毒的易感性：一项队列研究的结果
J Pers Med. 2022 Feb 25;12(3):352. doi: 10.3390/jpm12030352.
8
From H1N1 to COVID-19: What we have seen in children with hemoglobinopathies.从 H1N1 到 COVID-19：我们在患有血红蛋白病的儿童中看到的情况。
Clinics (Sao Paulo). 2022 Jan 29;77:100004. doi: 10.1016/j.clinsp.2021.100004. eCollection 2022.
9
Understanding the impact of COVID-19 pandemic on health-related quality of life amongst Iranian patients with beta thalassemia major: a grounded theory.理解 COVID-19 大流行对伊朗重型β地中海贫血患者健康相关生活质量的影响：扎根理论。
Prim Health Care Res Dev. 2021 Nov 10;22:e67. doi: 10.1017/S146342362100013X.
10
COVID-19 and Hemoglobinopathies: A Systematic Review of Clinical Presentations, Investigations, and Outcomes.新型冠状病毒肺炎与血红蛋白病：临床表现、检查及预后的系统评价
Front Med (Lausanne). 2021 Oct 13;8:757510. doi: 10.3389/fmed.2021.757510. eCollection 2021.
本文引用的文献
1
Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the "high clinical risk" category?严重急性呼吸综合征冠状病毒2感染在地中海贫血中的影响：患者是否属于“高临床风险”类别？
Acta Biomed. 2020 May 11;91(2):50-56. doi: 10.23750/abm.v91i2.9592.
2
SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience.β地中海贫血患者的新型冠状病毒2型感染：来自意大利经验的初步数据。
Am J Hematol. 2020 Aug;95(8):E198-E199. doi: 10.1002/ajh.25840. Epub 2020 May 6.
3
Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.儿童冠状病毒感染包括 COVID-19：儿童流行病学、临床特征、诊断、治疗和预防选择概述。
Pediatr Infect Dis J. 2020 May;39(5):355-368. doi: 10.1097/INF.0000000000002660.
4
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.实时 RT-PCR 检测 2019 新型冠状病毒（2019-nCoV）
Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000045.
5
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
6
Thalassaemia.地中海贫血症。
Lancet. 2018 Jan 13;391(10116):155-167. doi: 10.1016/S0140-6736(17)31822-6. Epub 2017 Jul 31.
7
Guidelines for diagnosis and management of Beta-thalassemia intermedia.中间型β地中海贫血的诊断与管理指南
Pediatr Hematol Oncol. 2014 Oct;31(7):583-96. doi: 10.3109/08880018.2014.937884.
Zotero 插件